为什么镇静催眠药在发育过程中经常失败
1Faculty of Health: Medicine, Dentistry and Human Sciences, University of Plymouth, Plymouth, UK.
Current opinion in anaesthesiology
|June 6, 2024
概括
用于麻醉和镇静的药物开发速度缓慢,除了对现有药物进行重制之外,很少有创新. 需要新的方法来改善患者的治疗结果,并证明在这个竞争激烈的市场上开发成本是合理的.
科学领域:
- 麻醉学 麻醉学
- 药理学 药理学是指药理学的学科.
- 药物开发 药物开发
背景情况:
- 麻醉和镇静的药物开发已经看到有限的创新.
- 现有市场主要以低成本的通用药物为主.
- 新的化合物并没有显示出对患者结局的显著改善.
研究的目的:
- 审查目前麻醉和镇静药物开发的现状.
- 确定这一领域的创新挑战和机遇.
- 探索推进药物开发的潜在策略.
主要方法:
- 最近的临床前和临床研究的文献综述.
- 对现有的麻醉和镇静剂的市场分析.
- 讨论科学和专业挑战.
主要成果:
- 从临床前研究中出现的新药候选药物很少.
- 现有化合物的重制是主要的创新策略.
- 目前的开发化合物缺乏独特的特征来证明成本的合理性.
结论:
- 有意义的进步需要基础科学的进步,而不仅仅是重新制定.
- 需要采取更大胆的举措,而不仅仅是修改普罗波福.
- 扩大开发范围,包括非麻醉师提供者,可以推动成本效益高的护理变化.
相关概念视频
Sedatives and Hypnotics: Overview
341
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
341
Sedatives and Hypnotics Drugs: Miscellaneous Agents
168
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
168
Sedatives and Hypnotics Drugs: Benzodiazepines
236
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
236
Sedatives and Hypnotics Drugs: Barbiturates
248
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
248
CNS Depressants: Barbiturates and Benzodiazepines
250
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
250
Management of Insomnia
244
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
244


